Erschienen in:
05.09.2023 | ASO Author Reflections
ASO Author Reflections: Localized Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer—Are They Candidates for Radical Resection?
verfasst von:
Aina Kunitomo, MD, Akira Ouchi, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 13/2023
Einloggen, um Zugang zu erhalten
Excerpt
A recent multicenter, randomized, phase III trial (PRODIGE7)
1 showed no survival benefit of hyperthermic intraperitoneal chemotherapy (HIPEC), and a reliable treatment for peritoneal metastases (PM) from colorectal cancer (CRC) has yet to be established. Two previous studies
2,3 reported that patients with CRC who underwent radical resection of synchronous PM with the primary tumor had better survival than non-surgical treatment. On the other hand, little evidence
4 exists regarding the significance of radical resection for metachronous PM. …